Youngchang Chemical Co Ltd
KOSDAQ:112290
Balance Sheet
Balance Sheet Decomposition
Youngchang Chemical Co Ltd
Youngchang Chemical Co Ltd
Balance Sheet
Youngchang Chemical Co Ltd
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
1 058
|
947
|
862
|
975
|
8 158
|
3 028
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
1 058
|
947
|
862
|
975
|
8 158
|
3 028
|
|
| Short-Term Investments |
672
|
106
|
37
|
28 809
|
19 638
|
20 828
|
|
| Total Receivables |
5 312
|
5 228
|
6 266
|
7 971
|
6 020
|
7 924
|
|
| Accounts Receivables |
5 312
|
4 991
|
6 040
|
7 795
|
5 745
|
7 603
|
|
| Other Receivables |
0
|
237
|
226
|
176
|
275
|
321
|
|
| Inventory |
7 300
|
8 370
|
9 603
|
11 349
|
12 827
|
10 651
|
|
| Other Current Assets |
1 254
|
1 559
|
1 420
|
1 468
|
820
|
1 117
|
|
| Total Current Assets |
15 596
|
16 210
|
18 188
|
50 573
|
47 463
|
43 549
|
|
| PP&E Net |
42 654
|
57 879
|
58 726
|
60 762
|
63 879
|
67 160
|
|
| PP&E Gross |
0
|
57 879
|
58 726
|
60 762
|
63 879
|
67 160
|
|
| Accumulated Depreciation |
0
|
17 434
|
21 082
|
25 137
|
29 311
|
32 052
|
|
| Intangible Assets |
1 447
|
1 363
|
582
|
671
|
1 193
|
1 278
|
|
| Long-Term Investments |
3 251
|
2 506
|
2 564
|
2 705
|
2 691
|
2 268
|
|
| Other Long-Term Assets |
0
|
543
|
1 651
|
1 377
|
4 343
|
2 025
|
|
| Total Assets |
62 948
N/A
|
78 501
+25%
|
81 711
+4%
|
116 088
+42%
|
119 569
+3%
|
116 280
-3%
|
|
| Liabilities | |||||||
| Accounts Payable |
4 727
|
6 169
|
5 275
|
4 514
|
3 729
|
3 903
|
|
| Accrued Liabilities |
0
|
327
|
354
|
383
|
524
|
536
|
|
| Short-Term Debt |
17 255
|
20 894
|
23 720
|
23 370
|
27 490
|
38 640
|
|
| Current Portion of Long-Term Debt |
3 424
|
4 892
|
8 075
|
5 054
|
8 191
|
5 206
|
|
| Other Current Liabilities |
11 402
|
12 503
|
1 682
|
2 245
|
1 710
|
2 284
|
|
| Total Current Liabilities |
36 809
|
44 785
|
39 106
|
35 566
|
41 643
|
50 569
|
|
| Long-Term Debt |
12 451
|
18 248
|
14 832
|
12 915
|
17 186
|
20 907
|
|
| Deferred Income Tax |
955
|
266
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
60
|
60
|
60
|
60
|
254
|
304
|
|
| Total Liabilities |
50 275
N/A
|
63 359
+26%
|
53 998
-15%
|
48 541
-10%
|
59 083
+22%
|
71 780
+21%
|
|
| Equity | |||||||
| Common Stock |
600
|
6 000
|
8 057
|
10 111
|
10 111
|
10 111
|
|
| Retained Earnings |
12 183
|
14 689
|
13 875
|
18 040
|
10 977
|
5 013
|
|
| Additional Paid In Capital |
0
|
5 436
|
5 893
|
39 509
|
39 509
|
39 509
|
|
| Unrealized Security Profit/Loss |
0
|
110
|
111
|
113
|
111
|
107
|
|
| Other Equity |
110
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
12 673
N/A
|
15 142
+19%
|
27 713
+83%
|
67 547
+144%
|
60 486
-10%
|
44 500
-26%
|
|
| Total Liabilities & Equity |
62 948
N/A
|
78 501
+25%
|
81 711
+4%
|
116 088
+42%
|
119 569
+3%
|
116 280
-3%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
10
|
10
|
10
|
10
|
10
|
10
|
|